Dunhill Financial’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.42K Sell
7
-2
-22% -$414 ﹤0.01% 890
2025
Q4
$1.87K Hold
9
﹤0.01% 758
2025
Q3
$1.63K Hold
9
﹤0.01% 723
2025
Q2
$1.46K Hold
9
﹤0.01% 729
2025
Q1
$1.54K Hold
9
﹤0.01% 775
2024
Q4
$1.51K Hold
9
﹤0.01% 730
2024
Q3
$1.55K Hold
9
﹤0.01% 752
2024
Q2
$1.39K Hold
9
﹤0.01% 640
2024
Q1
$1.38K Hold
9
﹤0.01% 579
2023
Q4
$1.42K Buy
+9
New +$1.29K ﹤0.01% 522

Other funds holding FBT

Dunhill Financial's FBT Position: Q1 2026 in Review

Dunhill Financial reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 22% in Q1 2026, selling an estimated $414 and leaving 7 shares worth $1.42K. The position accounts for ﹤0.01% of the portfolio, ranked #890.

Dunhill Financial first reported a position in FBT in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.87K in Q4 2025. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

  • Dunhill Financial held 7 shares of First Trust NYSE Arca Biotechnology Index Fund worth $1.42K as of Q1 2026.
  • Dunhill Financial sold 2 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $414.
  • First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Dunhill Financial's portfolio in Q1 2026, its #890 holding.
  • Dunhill Financial first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2023 and has held it in 10 quarters since.
  • Dunhill Financial's First Trust NYSE Arca Biotechnology Index Fund position peaked at $1.87K in Q4 2025.
  • 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Dunhill Financial's 13F filing for Q1 2026, filed 6 May 2026.